Speaking after a meeting of the country’s Coronavirus Scientific Advisory Board, Fahrettin Koca said the first 58,000 doses of the vaccine, which will be used in tests, have arrived in Turkey.
Koca said “4.5 million more doses will arrive this month to be administered. Meanwhile, tests of the vaccine will be completed.”
He added that the vaccine will be administered to those whose turn it is. As of next week, vaccination of those aged between 60-65 will be started, he said.
By anticipating possible problems with vaccine supply, he said the country took concrete steps in overcoming issues with global vaccine access and developing a domestic vaccine.
Underlining that mutant variants of the virus have been observed in Turkey, Koca said mutant viruses can be transmitted easier.
Urging people not to underestimate the virus, he highlighted the importance of strictly following measures.
“Unfortunately, there has been an increase in cases in most of our provinces in the last 15 days,” he said, adding the results have not started to be reflected in hospitals yet.
Noting that COVID-19 will no longer be a mass problem within months, he said: “Humanity has overcome the desperation of 2020. 2021 is the year of hope and victory.”
The Pfizer-BioNTech vaccine was developed by Özlem Türeci and Uğur Şahin, a couple who are both children of Turkish immigrants in Germany.
BioNTech aims to produce a total of 2 billion doses of the vaccine this year at six production facilities in various countries.
In January, Turkey began a mass COVID-19 vaccination campaign, and a gradual normalization from coronavirus restrictions began on March 1.
More than 12.35 million doses of a Chinese vaccine have been administered across Turkey so far, according to official figures.
Hurriyet Daily News